Breaking News Instant updates and real-time market news.

ERI

Eldorado Resorts

$15.16 /

+ (+0.00%)

09:44
03/30/20
03/30
09:44
03/30/20
09:44

Eldorado Resorts trading resumes

ERI Eldorado Resorts
$15.16 /

+ (+0.00%)

03/11/20 SunTrust
Eldorado Resorts likely to close Caesars deal in April, says SunTrust
01/08/20 Stifel
Eldorado Resorts named top Gaming & Leisure idea for 2020 at Stifel
12/24/19 Morgan Stanley
Morgan Stanley sees positive read to Boyd and peers from DraftKings' valuation
12/12/19 Roth Capital
Eldorado Resorts price target raised to $75 from $65 at Roth Capital

TODAY'S FREE FLY STORIES

Recommendations
Dollar General price target raised to $210 from $200 at KeyBanc » 08:35
05/29/20
05/29
08:35
05/29/20
08:35
DG

Dollar General

$184.09 /

-2.715 (-1.45%)

KeyBanc analyst Bradley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

08:23 Today BMO Capital
Dollar General price target raised to $200 from $175 at BMO Capital
08:20 Today Loop Capital
Dollar General price target raised to $190 from $175 at Loop Capital
05/28/20 Wells Fargo
Wells says Dollar General 'in a league of its own' after 'standout quarter'
05/26/20 Deutsche Bank
Dollar General price target raised to $187 from $159 at Deutsche Bank
DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

DG Dollar General
$184.09 /

-2.715 (-1.45%)

Recommendations
Toll Brothers price target raised to $36 from $27 at Keefe Bruyette » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
TOL

Toll Brothers

$32.30 /

-0.65 (-1.97%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

07:09 Today RBC Capital
Toll Brothers price target raised to $37 from $31 at RBC Capital
05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

TOL Toll Brothers
$32.30 /

-0.65 (-1.97%)

Hot Stocks
Heat Biologics presents HS-110/Opdivo combination Phase 2 trial data at ASCO » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
HTBX

Heat Biologics

$1.11 /

+0.156 (+16.35%)

, BMY

Bristol-Myers

$59.80 /

-0.59 (-0.98%)

Heat Biologics (HTBX)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HTBX Heat Biologics
$1.11 /

+0.156 (+16.35%)

BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

HTBX Heat Biologics
$1.11 /

+0.156 (+16.35%)

03/05/20 Maxim
Heat Biologics price target raised to $2 at Maxim after COVID-19 vaccine deal
02/06/20 Maxim
Heat Biologics initiated with a Buy at Maxim
02/06/20 Maxim
Heat Biologics initiated with a Buy at Maxim
07/29/19 Brookline
Heat Biologics initiated with a Buy at Brookline
BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
05/13/20 Piper Sandler
Bluebird should be able to easily address RTF issues, says Piper Sandler
05/12/20 Oppenheimer
Bluebird Bio price target lowered to $111 from $122 at Oppenheimer
04/20/20 Piper Sandler
Exelixis combo approval would increase kidney cancer use, says Piper Sandler
BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

BMY Bristol-Myers
$59.80 /

-0.59 (-0.98%)

Hot Stocks
AcelRx raises consideration to acquire Tetraphase » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
ACRX

AcelRx

$1.50 /

-0.055 (-3.55%)

, TTPH

Tetraphase

$2.24 /

+0.04 (+1.82%)

AcelRx Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACRX AcelRx
$1.50 /

-0.055 (-3.55%)

TTPH Tetraphase
$2.24 /

+0.04 (+1.82%)

ACRX AcelRx
$1.50 /

-0.055 (-3.55%)

05/07/20 Gabelli
Tetraphase upgraded to Hold from Sell at Gabelli
03/17/20 H.C. Wainwright
AcelRx price target lowered to $7 from $9 at H.C. Wainwright
03/17/20 Gabelli
Tetraphase downgraded to Sell from Hold at Gabelli
11/11/19 Credit Suisse
Credit Suisse downgrades AcelRx to Neutral, cuts target to $2 from $7
TTPH Tetraphase
$2.24 /

+0.04 (+1.82%)

05/07/20 Gabelli
Tetraphase upgraded to Hold from Sell at Gabelli
03/17/20 H.C. Wainwright
AcelRx price target lowered to $7 from $9 at H.C. Wainwright
03/17/20 Gabelli
Tetraphase downgraded to Sell from Hold at Gabelli
01/24/20 Gabelli
Tetraphase downgraded to Hold on fundraising dilution at Gabelli
ACRX AcelRx
$1.50 /

-0.055 (-3.55%)

ACRX AcelRx
$1.50 /

-0.055 (-3.55%)

TTPH Tetraphase
$2.24 /

+0.04 (+1.82%)

Hot Stocks
Defense Innovation Unit picks Zscaler for secure cloud management project » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
ZS

Zscaler

$75.88 /

+1.34 (+1.80%)

Zscaler announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

08:16 Today DA Davidson
Zscaler price target raised to $105 from $65 at DA Davidson
07:39 Today Cowen
Zscaler price target raised to $100 from $80 at Cowen
07:16 Today Wedbush
Zscaler price target raised to $100 from $80 at Wedbush
06:32 Today Credit Suisse
Zscaler price target raised to $90 from $75 at Credit Suisse
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

Earnings
Humana reaffirms FY20 adjusted EPS view of $18.25-$18.75, consensus $18.54 » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
HUM

Humana

$403.99 /

+4.315 (+1.08%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$403.99 /

+4.315 (+1.08%)

HUM Humana
$403.99 /

+4.315 (+1.08%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
HUM Humana
$403.99 /

+4.315 (+1.08%)

HUM Humana
$403.99 /

+4.315 (+1.08%)

HUM Humana
$403.99 /

+4.315 (+1.08%)

HUM Humana
$403.99 /

+4.315 (+1.08%)

Initiation
Everbridge assumed with a Buy at Canaccord » 08:34
05/29/20
05/29
08:34
05/29/20
08:34
EVBG

Everbridge

$137.04 /

-1.27 (-0.92%)

Canaccord analyst T.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVBG Everbridge
$137.04 /

-1.27 (-0.92%)

EVBG Everbridge
$137.04 /

-1.27 (-0.92%)

05/20/20 Stifel
Everbridge price target raised to $160 from $130 at Stifel
05/06/20 Canaccord
Everbridge price target raised to $135 from $125 at Canaccord
05/06/20 Baird
Everbridge price target raised to $132 from $120 at Baird
05/06/20 Credit Suisse
Everbridge price target raised to $118 from $95 at Credit Suisse
EVBG Everbridge
$137.04 /

-1.27 (-0.92%)

Conference/Events
Amgen to host conference call » 08:33
05/29/20
05/29
08:33
05/29/20
08:33
AMGN

Amgen

$224.02 /

-0.79 (-0.35%)

Research &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$224.02 /

-0.79 (-0.35%)

AMGN Amgen
$224.02 /

-0.79 (-0.35%)

05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/28/20 Cowen
Alexion settlement may yield upside surprise, says Cowen
05/28/20 Stifel
Alexion, Amgen appear to have agreed to settlement deal, says Stifel
05/22/20 Piper Sandler
Harpoon Therapeutics initiated with an Overweight at Piper Sandler
AMGN Amgen
$224.02 /

-0.79 (-0.35%)

AMGN Amgen
$224.02 /

-0.79 (-0.35%)

AMGN Amgen
$224.02 /

-0.79 (-0.35%)

Hot Stocks
NovaGold calls short seller report 'misleading', 'inaccurate' » 08:33
05/29/20
05/29
08:33
05/29/20
08:33
NG

NovaGold

$9.73 /

-0.915 (-8.60%)

NOVAGOLD RESOURCES…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NG NovaGold
$9.73 /

-0.915 (-8.60%)

NG NovaGold
$9.73 /

-0.915 (-8.60%)

Recommendations
VMware price target raised to $170 from $160 at KeyBanc » 08:33
05/29/20
05/29
08:33
05/29/20
08:33
VMW

VMware

$142.79 /

+3.18 (+2.28%)

KeyBanc analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

07:37 Today Morgan Stanley
VMware price target raised to $149 from $136 at Morgan Stanley
07:05 Today RBC Capital
VMware price target raised to $181 from $165 at RBC Capital
06:46 Today Mizuho
VMware price target raised to $152 from $140 at Mizuho
04:56 Today Jefferies
VMware price target raised to $160 from $135 at Jefferies
VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

VMW VMware
$142.79 /

+3.18 (+2.28%)

Recommendations
Hamilton Lane price target raised to $72 from $56 at Keefe Bruyette » 08:33
05/29/20
05/29
08:33
05/29/20
08:33
HLNE

Hamilton Lane

$72.14 /

-0.11 (-0.15%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HLNE Hamilton Lane
$72.14 /

-0.11 (-0.15%)

HLNE Hamilton Lane
$72.14 /

-0.11 (-0.15%)

03/29/20 Keefe Bruyette
Hamilton Lane upgraded to Market Perform from Underperform at Keefe Bruyette
02/07/20
Fly Intel: Top five analyst initiations
02/07/20 William Blair
Hamilton Lane initiated with an Outperform at William Blair
12/19/19 Wells Fargo
Wells stays bullish on alternative asset managers into 2020, Ares top pick
HLNE Hamilton Lane
$72.14 /

-0.11 (-0.15%)

HLNE Hamilton Lane
$72.14 /

-0.11 (-0.15%)

Hot Stocks
Galera announces data from restrospective anaylsis of avasopasem manganese » 08:32
05/29/20
05/29
08:32
05/29/20
08:32
GRTX

Galera Therapeutics

$10.66 /

-0.63 (-5.58%)

Galera Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRTX Galera Therapeutics
$10.66 /

-0.63 (-5.58%)

GRTX Galera Therapeutics
$10.66 /

-0.63 (-5.58%)

12/02/19 BTIG
Galera Therapeutics initiated with a Buy at BTIG
12/02/19 Credit Suisse
Galera Therapeutics initiated with a Neutral at Credit Suisse
12/02/19 Citi
Galera Therapeutics initiated with a Buy at Citi
12/02/19 BofA/Merrill
Galera Therapeutics initiated with a Buy at BofA/Merrill
GRTX Galera Therapeutics
$10.66 /

-0.63 (-5.58%)

Syndicate
BridgeBio 2.4M share Block Trade priced at $33.65 » 08:32
05/29/20
05/29
08:32
05/29/20
08:32
BBIO

BridgeBio

$35.11 /

-0.58 (-1.63%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$35.11 /

-0.58 (-1.63%)

BBIO BridgeBio
$35.11 /

-0.58 (-1.63%)

05/19/20 BTIG
BridgeBio initiated with a Buy at BTIG
05/11/20 Piper Sandler
Piper Sandler says BridgeBio's Infigratinib 'attractive candidate' for ACH
04/13/20 H.C. Wainwright
BridgeBio initiated with a Buy at H.C. Wainwright
02/19/20
Fly Intel: Top five analyst initiations
BBIO BridgeBio
$35.11 /

-0.58 (-1.63%)

  • 29
    May
BBIO BridgeBio
$35.11 /

-0.58 (-1.63%)

BBIO BridgeBio
$35.11 /

-0.58 (-1.63%)

Hot Stocks
ImmunoGen announces initial data from FORWARD II study at ASCO » 08:32
05/29/20
05/29
08:32
05/29/20
08:32
IMGN

ImmunoGen

$4.80 /

-0.07 (-1.44%)

ImmunoGen announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMGN ImmunoGen
$4.80 /

-0.07 (-1.44%)

IMGN ImmunoGen
$4.80 /

-0.07 (-1.44%)

05/04/20 H.C. Wainwright
ImmunoGen shares offer 'compelling entry point,' says H.C. Wainwright
12/17/19 H.C. Wainwright
ImmunoGen price target hiked to $9 after 'compelling' advance at H.C. Wainwright
09/29/19 Piper Jaffray
Biomarker screening reason for ImmunoGen FORWARD I failure, says Piper Jaffray
IMGN ImmunoGen
$4.80 /

-0.07 (-1.44%)

IMGN ImmunoGen
$4.80 /

-0.07 (-1.44%)

Hot Stocks
AgeX Therapeutics announces collaboration with Sernova » 08:31
05/29/20
05/29
08:31
05/29/20
08:31
AGE

AgeX Therapeutics

$0.78 /

+0.0082 (+1.06%)

AgeX Therapeutics and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGE AgeX Therapeutics
$0.78 /

+0.0082 (+1.06%)

Hot Stocks
Nabriva gets 'positive' EU CHMP opinion for Xenleta for CAP treatment » 08:31
05/29/20
05/29
08:31
05/29/20
08:31
NBRV

Nabriva Therapeutics

$0.85 /

+0.0063 (+0.74%)

Nabriva Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NBRV Nabriva Therapeutics
$0.85 /

+0.0063 (+0.74%)

NBRV Nabriva Therapeutics
$0.85 /

+0.0063 (+0.74%)

04/23/20 Northland
Nabriva Therapeutics price target lowered to $2.50 from $5 at Northland
04/09/20 H.C. Wainwright
Nabriva Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
04/08/20 Needham
Nabriva Therapeutics downgraded to Hold from Buy at Needham
03/24/20 H.C. Wainwright
Paratek, Nabriva can benefit from DISARM Act passage, says H.C. Wainwright
NBRV Nabriva Therapeutics
$0.85 /

+0.0063 (+0.74%)

Hot Stocks
Rapt Therapeutics announces poster presentation for Phase 1/2 trial of FLX475 » 08:30
05/29/20
05/29
08:30
05/29/20
08:30
RAPT

Rapt Therapeutics

$17.51 /

-0.5 (-2.78%)

RAPT Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$17.51 /

-0.5 (-2.78%)

RAPT Rapt Therapeutics
$17.51 /

-0.5 (-2.78%)

05/19/20
Fly Intel: Top five analyst initiations
05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/18/20 Cantor Fitzgerald
Rapt Therapeutics initiated with an Overweight at Cantor Fitzgerald
04/13/20
Fly Intel: Top five analyst initiations
RAPT Rapt Therapeutics
$17.51 /

-0.5 (-2.78%)

Options
One new option listing and one option delisting on May 29th » 08:30
05/29/20
05/29
08:30
05/29/20
08:30
LRMR

Larimar Therapeutics

$1.00 /

-0.155 (-13.42%)

, ZFGN

Zafgen

$0.00 /

+ (+0.00%)

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRMR Larimar Therapeutics
$1.00 /

-0.155 (-13.42%)

ZFGN Zafgen
$0.00 /

+ (+0.00%)

LRMR Larimar Therapeutics
$1.00 /

-0.155 (-13.42%)

ZFGN Zafgen
$0.00 /

+ (+0.00%)

09/06/19 Roth Capital
Zafgen downgraded to Neutral from Buy at Roth Capital
09/06/19 Wedbush
Zafgen downgraded to Neutral at Wedbush, price target slashed to 78c
09/06/19 Wedbush
Zafgen downgraded to Neutral from Outperform at Wedbush
09/05/19 JMP Securities
Zafgen downgraded to Market Perform from Outperform at JMP Securities
Hot Stocks
Athenex presents interim data from oral paclitaxel Phase II study » 08:28
05/29/20
05/29
08:28
05/29/20
08:28
ATNX

Athenex

$11.12 /

-0.35 (-3.05%)

Athenex presented interim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATNX Athenex
$11.12 /

-0.35 (-3.05%)

ATNX Athenex
$11.12 /

-0.35 (-3.05%)

12/13/19 RBC Capital
Athenex oraxol OS and ORR a 'best case,' buy on weakness, says RBC Capital
12/06/19 SunTrust
Athenex initiated with a Buy at SunTrust
11/19/19 RBC Capital
Athenex gets 'third SABCS win' ahead of meeting, says RBC Capital
08/07/19 RBC Capital
Athenex's Oraxol data 'near best-case,' says RBC Capital
ATNX Athenex
$11.12 /

-0.35 (-3.05%)

ATNX Athenex
$11.12 /

-0.35 (-3.05%)

Hot Stocks
Communications Systems makes minority investment in Quortus » 08:27
05/29/20
05/29
08:27
05/29/20
08:27
JCS

Communications Systems

$5.06 /

-0.04 (-0.78%)

Communications Systems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
Hot Stocks
Hutchison China MediTech reveals analyses on the ongoing studies of savolitinib » 08:27
05/29/20
05/29
08:27
05/29/20
08:27
HCM

Hutchison China MediTech

$21.24 /

+1.3 (+6.52%)

Hutchison China MediTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCM Hutchison China MediTech
$21.24 /

+1.3 (+6.52%)

HCM Hutchison China MediTech
$21.24 /

+1.3 (+6.52%)

03/13/20
Fly Intel: Top analyst initiations
03/12/20 Cantor Fitzgerald
Hutchison China MediTech initiated with an Overweight at Cantor Fitzgerald
02/20/20
Fly Intel: Top five analyst initiations
02/20/20 Goldman Sachs
Hutchison China MediTech initiated with a Buy at Goldman Sachs
Hot Stocks
IMV Inc. reports updated clinical response, data from DeCidE1 study » 08:27
05/29/20
05/29
08:27
05/29/20
08:27
IMV

IMV Inc.

$3.05 /

-0.09 (-2.87%)

IMV Inc. reported updated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMV IMV Inc.
$3.05 /

-0.09 (-2.87%)

IMV IMV Inc.
$3.05 /

-0.09 (-2.87%)

05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight on COVID-19 vaccine potential at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
05/15/20 H.C. Wainwright
IMV Inc. price target raised to $13 from $11.50 at H.C. Wainwright
04/01/20 B. Riley FBR
IMV Inc. downgraded to Neutral from Buy at B. Riley FBR
Hot Stocks
Chondrial, Zafgen complete merger, begin operations as Larimar Therapeutics » 08:27
05/29/20
05/29
08:27
05/29/20
08:27
LRMR

Larimar Therapeutics

$1.00 /

-0.155 (-13.42%)

, ZFGN

Zafgen

$0.00 /

+ (+0.00%)

Chondrial Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZFGN Zafgen
$0.00 /

+ (+0.00%)

LRMR Larimar Therapeutics
$1.00 /

-0.155 (-13.42%)

ZFGN Zafgen
$0.00 /

+ (+0.00%)

09/06/19 Roth Capital
Zafgen downgraded to Neutral from Buy at Roth Capital
09/06/19 Wedbush
Zafgen downgraded to Neutral at Wedbush, price target slashed to 78c
09/06/19 Wedbush
Zafgen downgraded to Neutral from Outperform at Wedbush
09/05/19 JMP Securities
Zafgen downgraded to Market Perform from Outperform at JMP Securities
Hot Stocks
Ligand announces expansion of Icagen license agreement with Roche » 08:26
05/29/20
05/29
08:26
05/29/20
08:26
LGND

Ligand

$100.62 /

-4.16 (-3.97%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Ligand Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LGND Ligand
$100.62 /

-4.16 (-3.97%)

RHHBY Roche
$0.00 /

+ (+0.00%)

LGND Ligand
$100.62 /

-4.16 (-3.97%)

04/29/20 Craig-Hallum
Ligand has 'significant upside' if remdesivir is approved, says Craig-Hallum
04/08/20 H.C. Wainwright
Ligand price target lowered to $229 from $237 at H.C. Wainwright
04/06/20 H.C. Wainwright
H.C. Wainwright says Captisol a 'key focus' for Ligand, reiterates Buy
03/24/20 Argus
Ligand downgraded to Hold from Buy at Argus
RHHBY Roche
$0.00 /

+ (+0.00%)

05/15/20 Barclays
Roche price target raised to CHF 395 from CHF 385 at Barclays
05/14/20 Mizuho
Arcus Biosciences price target raised to $40 from $22 at Mizuho
05/13/20 Wolfe Research
Roche upgraded to Outperform from Peer Perform at Wolfe Research
05/13/20 Wolfe Research
Roche upgraded to Outperform from Peer Perform at Wolfe Research
LGND Ligand
$100.62 /

-4.16 (-3.97%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

LGND Ligand
$100.62 /

-4.16 (-3.97%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Recommendations
Slack Technologies price target raised to $37 from $32 at Stephens » 08:25
05/29/20
05/29
08:25
05/29/20
08:25
WORK

Slack Technologies

$32.56 /

+0.43 (+1.34%)

Stephens analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

05/27/20 Baird
Slack Technologies price target raised to $36 from $24 at Baird
04/16/20 Credit Suisse
Slack Technologies price target raised to $26 from $21 at Credit Suisse
04/14/20
Fly Intel: Top five analyst initiations
04/14/20 Cantor Fitzgerald
Slack Technologies initiated with an Overweight at Cantor Fitzgerald
WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

WORK Slack Technologies
$32.56 /

+0.43 (+1.34%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.